CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade ProPhase Labs, Inc. - PRPH CFD

    5.03
    2.86%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.19
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026235 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026235%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.004012 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.004012%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* 4.89
    Open* 4.89
    1-Year Change* -52.25%
    Day's Range* 4.89 - 5.08
    52 wk Range 4.05-10.86
    Average Volume (10 days) 34.10K
    Average Volume (3 months) 689.36K
    Market Cap 78.86M
    P/E Ratio -100.00K
    Shares Outstanding 18.05M
    Revenue 62.71M
    EPS -0.62
    Dividend (Yield %) N/A
    Beta -0.34
    Next Earnings Date Mar 26, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 1, 2023 4.89 0.00 0.00% 4.89 4.97 4.88
    Nov 30, 2023 5.05 0.13 2.64% 4.92 5.29 4.84
    Nov 29, 2023 4.65 0.19 4.26% 4.46 4.72 4.46
    Nov 28, 2023 4.58 0.19 4.33% 4.39 4.73 4.36
    Nov 27, 2023 4.56 0.17 3.87% 4.39 4.60 4.39
    Nov 24, 2023 4.46 0.08 1.83% 4.38 4.46 4.38
    Nov 22, 2023 4.43 0.09 2.07% 4.34 4.56 4.31
    Nov 21, 2023 4.35 0.01 0.23% 4.34 4.50 4.29
    Nov 20, 2023 4.45 0.22 5.20% 4.23 4.50 4.23
    Nov 17, 2023 4.40 0.10 2.33% 4.30 4.48 4.30
    Nov 16, 2023 4.34 0.00 0.00% 4.34 4.37 4.28
    Nov 15, 2023 4.33 0.00 0.00% 4.33 4.34 4.23
    Nov 14, 2023 4.34 -0.14 -3.13% 4.48 4.54 4.33
    Nov 13, 2023 4.50 -0.11 -2.39% 4.61 4.71 4.50
    Nov 10, 2023 4.52 -0.28 -5.83% 4.80 4.80 4.44
    Nov 9, 2023 4.98 0.25 5.29% 4.73 5.08 4.65
    Nov 8, 2023 4.51 0.03 0.67% 4.48 4.54 4.44
    Nov 7, 2023 4.57 0.02 0.44% 4.55 4.58 4.52
    Nov 6, 2023 4.55 0.06 1.34% 4.49 4.79 4.49
    Nov 3, 2023 4.50 0.03 0.67% 4.47 4.59 4.45

    ProPhase Labs, Inc. Events

    Time (UTC) Country Event
    Tuesday, March 26, 2024

    Time (UTC)

    12:30

    Country

    US

    Event

    Q4 2023 Prophase Labs Inc Earnings Release
    Q4 2023 Prophase Labs Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 122.647 79.042 14.514 9.876 13.126
    Revenue 122.647 79.042 14.514 9.876 13.126
    Cost of Revenue, Total 51.993 37.054 9.908 7.261 8.345
    Gross Profit 70.654 41.988 4.606 2.615 4.781
    Total Operating Expense 99.052 69.241 16.607 13.115 14.76
    Selling/General/Admin. Expenses, Total 34.385 22.493 7.958 5.522 6.017
    Research & Development 0.652 0.52 0.633 0.332 0.398
    Operating Income 23.595 9.801 -2.093 -3.239 -1.634
    Interest Income (Expense), Net Non-Operating -0.687 -0.746 -0.233 0.133 0.167
    Other, Net 0 -3.75
    Net Income Before Taxes 22.908 5.305 -2.326 -3.106 -1.467
    Net Income After Taxes 18.463 6.273 -2.326 -3.106 -1.57
    Net Income Before Extra. Items 18.463 6.273 -2.326 -3.106 -1.57
    Total Extraordinary Items 0 0.201 -0.04 -0.17
    Net Income 18.463 6.273 -2.125 -3.146 -1.74
    Income Available to Common Excl. Extra. Items 18.463 6.273 -2.326 -3.106 -1.57
    Income Available to Common Incl. Extra. Items 18.463 6.273 -2.125 -3.146 -1.74
    Diluted Net Income 19.096 6.273 -2.125 -3.146 -1.74
    Diluted Weighted Average Shares 18.651 18.393 11.595 11.564 11.396
    Diluted EPS Excluding Extraordinary Items 1.02386 0.34105 -0.2006 -0.26859 -0.13777
    Diluted Normalized EPS 1.02386 0.34105 -0.36378 -0.26859 -0.13777
    Unusual Expense (Income) -1.892
    Other Operating Expenses, Total 12.022 9.174
    Gain (Loss) on Sale of Assets 0
    Dilution Adjustment 0.633
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 13.217 19.303 21.823 24.2 29.092
    Revenue 13.217 19.303 21.823 24.2 29.092
    Cost of Revenue, Total 6.769 8.783 10.54 12.227 10.372
    Gross Profit 6.448 10.52 11.283 11.973 18.72
    Total Operating Expense 17.875 18.428 26.913 22.247 18.505
    Selling/General/Admin. Expenses, Total 9.937 8.298 12.742 7.512 6.306
    Research & Development 0.572 0.144 0.478 0.11 0.028
    Other Operating Expenses, Total 0.597 1.203 3.153 2.398 1.799
    Operating Income -4.658 0.875 -5.09 1.953 10.587
    Interest Income (Expense), Net Non-Operating -0.264 -0.204 -0.099 -0.176 -0.176
    Net Income Before Taxes -4.914 0.564 -5.189 1.777 10.411
    Net Income After Taxes -3.44 0.55 -2.444 0.968 7.446
    Net Income Before Extra. Items -3.44 0.55 -2.444 0.968 7.446
    Net Income -3.44 0.55 -2.444 0.968 7.446
    Income Available to Common Excl. Extra. Items -3.44 0.55 -2.444 0.968 7.446
    Income Available to Common Incl. Extra. Items -3.44 0.55 -2.444 0.968 7.446
    Diluted Net Income -3.44 0.61 -2.444 1.169 7.646
    Diluted Weighted Average Shares 16.845 18.061 16.244 20.248 19.272
    Diluted EPS Excluding Extraordinary Items -0.20421 0.03377 -0.15046 0.05773 0.39674
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.20421 0.03377 -0.15046 0.05773 0.39674
    Gain (Loss) on Sale of Assets
    Other, Net 0.008 -0.107 0
    Total Extraordinary Items
    Dilution Adjustment 0.06 0.201 0.2
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 60.833 61.317 15.887 9.945 18.238
    Cash and Short Term Investments 17.437 17.263 8.455 1.36 8.241
    Cash & Equivalents 9.109 8.408 6.816 0.434 1.554
    Total Receivables, Net 37.054 37.708 3.155 2.01 2.968
    Accounts Receivable - Trade, Net 37.054 37.708 3.155 2.01 2.968
    Total Inventory 3.976 4.6 3.039 1.459 1.903
    Prepaid Expenses 2.366 1.496 1.238 0.304 0.296
    Total Assets 87.648 89.295 31.405 12.274 20.737
    Property/Plant/Equipment, Total - Net 11.347 10.349 8.309 2.329 2.499
    Property/Plant/Equipment, Total - Gross 19.787 17.232 13.33 8.581
    Accumulated Depreciation, Total -8.44 -6.883 -5.021 -6.252
    Total Current Liabilities 16.075 15.524 6.294 0.933 4.233
    Accounts Payable 5.905 7.026 3.771 0.432 0.437
    Accrued Expenses 3.481 4.814 2.055 0.397 0.101
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 6.689 3.684 0.468 0.104 3.695
    Total Liabilities 24.017 30.667 20.849 1.043 4.233
    Total Long Term Debt 2.4 10.04 9.991 0 0
    Other Liabilities, Total 5.318 5.103 4.564 0.11
    Total Equity 63.631 58.628 10.556 11.231 16.504
    Common Stock 0.016 0.016 0.014 0.014 0.014
    Additional Paid-In Capital 109.138 104.552 61.674 60.215 59.471
    Retained Earnings (Accumulated Deficit) 11.753 2.642 -3.631 -1.506 4.533
    Treasury Stock - Common -58.033 -48.407 -47.49 -47.49 -47.49
    Total Liabilities & Shareholders’ Equity 87.648 89.295 31.405 12.274 20.737
    Total Common Shares Outstanding 16.2108 15.4859 11.6042 11.5736 11.5495
    Short Term Investments 8.328 8.855 1.639 0.926 6.687
    Other Current Assets, Total 0 0.25 0 4.812 4.83
    Note Receivable - Long Term 0
    Other Equity, Total 0.757 -0.175 -0.011 -0.002 -0.024
    Goodwill, Net 5.709 5.709 0.901
    Intangibles, Net 8.475 10.852 1.234
    Other Long Term Assets, Total 1.284 1.068 5.074
    Long Term Debt 2.4 10.04 9.991
    Deferred Income Tax 0.224
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 49.794 54.966 61.279 60.833 70.326
    Cash and Short Term Investments 3.267 9.104 15.559 17.437 26.477
    Cash & Equivalents 0.702 3.824 9.613 9.109 22.799
    Short Term Investments 2.565 5.28 5.946 8.328 3.678
    Total Receivables, Net 38.642 38.572 37.836 37.054 37.832
    Accounts Receivable - Trade, Net 38.642 38.572 37.836 37.054 37.832
    Total Inventory 5.054 3.623 4.311 3.976 4.912
    Prepaid Expenses 2.831 3.667 3.573 2.366 1.105
    Total Assets 91.71 91.058 95.374 87.648 97.877
    Property/Plant/Equipment, Total - Net 17.843 13.619 12.865 11.347 10.211
    Property/Plant/Equipment, Total - Gross 19.787 18.125
    Accumulated Depreciation, Total -8.44 -7.914
    Goodwill, Net 5.231 5.231 5.231 5.709 5.709
    Intangibles, Net 13.015 13.769 14.524 8.475 8.889
    Other Long Term Assets, Total 5.827 3.473 1.475 1.284 2.742
    Total Current Liabilities 16.406 13.675 18.467 16.075 16.693
    Accounts Payable 5.467 4.786 4.866 5.905 1.545
    Accrued Expenses 1.301 1.527 0.802 3.481 3.538
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 7.798 6.998 12.799 6.689 11.61
    Total Liabilities 35.282 31.801 35.433 24.017 29.956
    Total Long Term Debt 4.436 3.49 2.4 2.4 7.999
    Long Term Debt 0 2.4 2.4 2.4 7.999
    Other Liabilities, Total 14.44 14.636 14.566 5.318 5.264
    Total Equity 56.428 59.257 59.941 63.631 67.921
    Common Stock 0.018 0.017 0.017 0.016 0.017
    Additional Paid-In Capital 118.132 113.789 111.482 109.138 108.131
    Retained Earnings (Accumulated Deficit) 3.722 8.863 12.303 11.753 14.198
    Treasury Stock - Common -64 -64 -63.953 -58.033 -54.138
    Other Equity, Total -1.444 0.588 0.092 0.757 -0.287
    Total Liabilities & Shareholders’ Equity 91.71 91.058 95.374 87.648 97.877
    Total Common Shares Outstanding 18.045 16.845 16.851 16.2108 16.0262
    Other Current Assets, Total 0 0
    Deferred Income Tax 0 0 0 0.224
    Current Port. of LT Debt/Capital Leases 1.84 0.364
    Capital Lease Obligations 4.436 1.09
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line 18.463 6.273 -2.125 -3.146 -1.74
    Cash From Operating Activities 28.551 -13.619 -2.592 -0.841 -2.119
    Cash From Operating Activities 4.718 3.234 0.449 0.398 0.383
    Non-Cash Items 9.71 11.489 -0.308 0.796 0.956
    Cash Interest Paid 0.763 1 0.25 0
    Changes in Working Capital -4.34 -34.615 -0.608 1.111 -1.718
    Cash From Investing Activities -2.077 -19.666 -1.016 5.543 11.862
    Capital Expenditures -3.919 -4.231 -1.689 -0.228 -0.14
    Other Investing Cash Flow Items, Total 1.842 -15.435 0.673 5.771 12.002
    Cash From Financing Activities -26.023 35.127 9.99 -5.822 -11.362
    Issuance (Retirement) of Debt, Net -7.044 -0.045 9.99 0
    Net Change in Cash 0.451 1.842 6.382 -1.12 -1.619
    Cash Taxes Paid 1.696 0 0 0.103 0.738
    Financing Cash Flow Items 0.001
    Issuance (Retirement) of Stock, Net -9.626 39.718 0.337
    Total Cash Dividends Paid -9.353 -4.546 -5.822 -11.7
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line 0.55 18.463 20.907 19.94 12.494
    Cash From Operating Activities 0.476 28.551 27.74 25.108 20.287
    Cash From Operating Activities 1.292 4.718 3.792 2.516 1.249
    Non-Cash Items 1.242 9.71 5.868 3.529 -0.101
    Cash Taxes Paid 1.5 1.696 -1.5 1.5 0
    Cash Interest Paid 0.203 0.763 0.631 0.441 0.241
    Changes in Working Capital -2.512 -4.34 -1.488 -0.283 6.202
    Cash From Investing Activities -1.652 -2.077 2.926 3.596 4.084
    Capital Expenditures -3.421 -3.919 -2.323 -1.769 -1.095
    Other Investing Cash Flow Items, Total 1.769 1.842 5.249 5.365 5.179
    Cash From Financing Activities 1.68 -26.023 -16.525 -13.403 -7.222
    Issuance (Retirement) of Stock, Net 1.68 -9.626 -5.73 -2.608 -1.15
    Net Change in Cash 0.504 0.451 14.141 15.301 17.149
    Total Cash Dividends Paid 0 -9.353 -9.351 -9.351 -4.646
    Financing Cash Flow Items
    Issuance (Retirement) of Debt, Net 0 -7.044 -1.444 -1.444 -1.426
    Deferred Taxes -0.096 -1.339 -0.594 0.443
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Karkus (Ted William) Individual Investor 21.2071 3572350 388600 2023-04-20 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.5728 601840 -14816 2023-06-30 LOW
    Renaissance Technologies LLC Hedge Fund 1.784 300510 -55000 2023-06-30 HIGH
    Gleckel (Louis) Individual Investor 1.6256 273840 0 2023-04-20
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.7904 133135 10105 2023-06-30 LOW
    Perritt Capital Management, Inc. Investment Advisor 0.5776 97300 0 2023-06-30 LOW
    Columbia Threadneedle Investments (US) Investment Advisor/Hedge Fund 0.5505 92729 4276 2023-06-30 LOW
    Brady (Monica L) Individual Investor 0.5429 91450 56578 2023-04-20 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 0.4905 82618 -22028 2023-06-30 LOW
    American Century Investment Management, Inc. Investment Advisor/Hedge Fund 0.4427 74567 -5599 2023-06-30 LOW
    O'Shaughnessy Asset Management, LLC Investment Advisor 0.3476 58559 4567 2023-06-30 MED
    GlobeFlex Capital, L.P. Investment Advisor 0.3335 56175 0 2023-06-30 LOW
    SVB Wealth LLC Investment Advisor 0.283 47665 47665 2023-09-30 LOW
    Koss-Olinger Consulting, LLC Investment Advisor 0.2498 42081 16922 2023-09-30 MED
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.2384 40163 0 2023-06-30 LOW
    Chapin Davis Asset Management Investment Advisor 0.2375 40000 10000 2023-09-30 LOW
    First Trust Advisors L.P. Investment Advisor 0.2216 37333 2228 2023-06-30 MED
    BofA Global Research (US) Research Firm 0.2195 36977 -216 2023-06-30 LOW
    Newton Investment Management North America, LLC Investment Advisor 0.2125 35795 0 2023-09-30 MED
    Bridgeway Capital Management, LLC Investment Advisor 0.1915 32256 -22137 2023-06-30 MED

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    ProPhase Labs, Inc. Company profile

    About ProPhase Labs Inc

    ProPhase Labs, Inc. is a medical science and technology company. The Company operates through two segments: consumer products and diagnostic services. The consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of over-the-counter (OTC) consumer healthcare products and dietary supplements in the United States. The diagnostic services segment provides COVID-19 diagnostic information services to a range of customers in the United States, including health plans, third party payers and government organizations. The Company is also engaged in development and distribution of a product line of OTC dietary supplements under the brand name of TK Supplements. The TK Supplements product line offers two men’s health products, including Legendz XL for sexual health and Triple Edge XL, an energy booster plus testosterone support.

    Financial summary

    BRIEF: For the nine months ended 30 September 2021, ProPhase Labs Inc revenues increased from $9.4M to $33.9M. Net loss before extraordinary items increased from $1.3M to $4.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects General and administration increase from $3.3M to $14.7M (expense).

    Equity composition

    Common Stock $.0005 Par, 12/10, 50M auth., 19,353,672 issd., less 4,646,053 shs. in Treas. @ $25.2M. Insiders & Stakeholder owns 43.95%. PO 2/91, 3M shares @ $.15 by Concorde Brokerage Corporation. 1/97, 2-for-1 stock split. FY '00 '01 fins. are RES due to disc. opr. Sum Qs reflect restated EPS. FY '02 Qs are restated for disc. opr.

    Industry: Special Foods & Wellbeing Products

    711 Stewart Ave, Suite 200
    Garden City
    NEW YORK
    NEW YORK 11530
    US

    Income Statement

    • Annual
    • Quarterly

    News

    December RBA preview: no move expected at the final meeting of 2023

    The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

    14:47, 4 December 2023

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023

    People also watch

    US100

    15,747.80 Price
    -1.690% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 1.8

    Oil - Crude

    73.71 Price
    -1.100% 1D Chg, %
    Long position overnight fee -0.0200%
    Short position overnight fee -0.0019%
    Overnight fee time 22:00 (UTC)
    Spread 0.030

    BTC/USD

    41,414.85 Price
    +4.020% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    Gold

    2,023.31 Price
    -2.180% 1D Chg, %
    Long position overnight fee -0.0200%
    Short position overnight fee 0.0118%
    Overnight fee time 22:00 (UTC)
    Spread 0.50

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading